Monoclonal Antibodies in Prevention and Early Treatment of COVID-19 in Lung Transplant Recipients: A Systematic Review and Perspective on the Role of Monoclonal Antibodies in the Future

Monoclonal Antibodies in Prevention and Early Treatment of COVID-19 in Lung Transplant Recipients: A Systematic Review and Perspective on the Role of Monoclonal Antibodies in the Future

Coronavirus disease 2019 (COVID-19) has significantly impacted lung transplant recipients (LTR), who remain vulnerable to severe COVID-19 despite vaccination, prompting the use of monoclonal antibodies (mAbs) as a treatment option. This systematic review summarizes the clinical efficacy of mAbs agai...

Full description

Saved in:
Bibliographic Details
Main Authors: David A. Van Eijndhoven, Robin Vos, Saskia Bos
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Transplant International
Subjects:
lung transplantation
COVID-19
Sars-CoV-2
monoclonal antibodies
tixagevimab/cilgavimab
sotrovimab
Online Access:https://www.frontierspartnerships.org/articles/10.3389/ti.2025.13800/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items